# Safe Threshold to Discontinue Phototherapy in Hemolytic Disease of Newborn

> **NCT04218318** · NA · RECRUITING · sponsor: **Ministry of Health, Saudi Arabia** · enrollment: 84 (estimated)

## Conditions studied

- Hemolytic Disease of Newborn
- Neonatal Hyperbilirubinemia

## Interventions

- **DEVICE:** phototherapy

## Key facts

- **NCT ID:** NCT04218318
- **Lead sponsor:** Ministry of Health, Saudi Arabia
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-10-01
- **Primary completion:** 2026-10-31
- **Final completion:** 2027-01-01
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2025-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04218318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04218318, "Safe Threshold to Discontinue Phototherapy in Hemolytic Disease of Newborn". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04218318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*